Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CGTX Cognition Therapeutics

Watchlist
2.120
+0.200+10.42%
Close  02/03 16:00 ET
2.100
-0.020-0.94%
Post Mkt Price 02/03 19:59 ET
High
2.140
Open
1.989
Turnover
480.53K
Low
1.840
Pre Close
1.920
Volume
240.57K
Market Cap
61.42M
P/E(TTM)
Loss
52wk High
6.269
Shares
28.97M
P/E(Static)
Loss
52wk Low
1.070
Float Cap
39.31M
Bid/Ask %
-40.00%
Historical High
13.800
Shs Float
18.54M
Volume Ratio
5.80
Historical Low
1.070
Dividend TTM
--
Div Yield TTM
--
P/B
1.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.30%
Amplitude
15.63%
Avg Price
1.997
Lot Size
1
Float Cap
39.31M
Bid/Ask %
-40.00%
Historical High
13.800
Shs Float
18.54M
Volume Ratio
5.80
Historical Low
1.070
Dividend TTM
--
P/B
1.56
Dividend LFY
--
Turnover Ratio
1.30%
Amplitude
15.63%
Avg Price
1.997
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. The firm develops drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano in 2007 and is headquartered in Purchase, NY.
CEO: Ms. Lisa Ricciardi
Market: NASDAQ
Listing Date: 10/08/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist